Advertisement

Pharmaceutisch weekblad

, Volume 1, Issue 1, pp 1459–1469 | Cite as

Biopharmaceutics of rectal administration of drugs in man

Absorption rate and bioavailability of acetylsalicylic acid and its calcium salt after oral and rectal administration
  • F. Moolenaar
  • N. J. J. Oldenhof
  • W. Groenewoud
  • T. Huizinga
Article

Abstract

Rectal absorption of acetylsalicylic acid and its calcium salt was studied in man and compared with oral absorption.

Plasma concentrations of acetylsalicylic acid and salicylic acid were measured by means ofHplc analysis, after a single dose of acetylsalicylic acid (500 mg) and after single rectal doses of acetylsalicylic acid (500 mg) and calcium acetylsalicylate (640 mg) in a cross-over study in 8 volunteers. The rectal dosage forms included fatty suppositories and aqueous solutions.

Compared with oral administration rectal absorption of acetylsalicylic acid can be equally rapid, if the volume and the pH of the aqueous micro-enema was optimized (20 ml, pH 4.0). Rectal absorption of calcium acetylsalicylate occurred very slowly. If fatty suppositories were used smaller particles favoured the rate of acetylsalicylic acid absorption. Compared with oral administration absorption from the optimized suppository dosage form proceeded significantly (P < 0.05) slower. For all rectal dosage forms, the extent to which acetylsalicylic acid reached the general circulation intact, was smaller than after oral administration.

Keywords

Salicylic Acid Dosage Form Acetylsalicylic Acid Cocoa Butter Sodium Salicylate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bywaters, E. G. L. (1963) Clinical implications of the antiinflammatory effects of salicylate. InSalicylates, an international symposium (A. St. J. Dixon, B. K. Martin, M. J. H. Smith andP. H. W. Wood, eds.), 154–160. Little Brown, Boston.Google Scholar
  2. Cacchillo, A. F., andW. H. Hassler (1954) The influence of suppository bases upon the rectal absorption of acetylsalicylic acid.J. Am. Pharm. Assoc. 43, 683–685.CrossRefGoogle Scholar
  3. Cid, E. (1974) Absorption rectale de médicaments. Influence de la taille des cristaux d'acide acetylsalicylique.Ann. Pharm. Franc. 32, 273–281.PubMedGoogle Scholar
  4. Coldwell, B. B., G. Solomonray, E. M. Boyd, J. Jantz andA. B. Morrison (1969) The effect of dosage form and route of administration on the absorption and excretion of acetylsalicylic acid in man.Clin. Toxicol. 2, 111–127.CrossRefGoogle Scholar
  5. Duthie, J. J. R. (1963) InSalicylates, an international symposium (A. St. J. Dixon, M. J. H. Smith, B. K. Martin andP. H. W. Wood, eds.), 288–292, Little Brown, Boston.Google Scholar
  6. Gibaldi, M., andB. Grundhofer (1975) Bioavailability of aspirin from commercial suppositories.J. Pharm. Sci. 64, 1064–1066.CrossRefPubMedGoogle Scholar
  7. Ginneken, C. A. M. Van (1976)Pharmacokinetics of antipyretic and anti-inflammatory analgesics. Thesis, Nijmegen.Google Scholar
  8. Houde, R. W., S. L. Wallenstein andW. T. Beaver (1965) Clinical measurement of pain. InAnalgetics (G. De Stevens, ed.), 76–122. Academic Press, New York.Google Scholar
  9. Lasagna, L. (1961) Progress of medical science: Analgesic drugs.Am. J. Med. Sci. (R. A. Kern, T. M. Durant andK. M. Schreck, eds.), Vol. 242, 620–627. Lea & Febiger, Philadelphia.Google Scholar
  10. Lester, D., G. Lolli andL. A. Greenberg (1946) The fate of acetylsalicylic acid.J. Pharmacol. Exp. Ther. 87, 329–342.PubMedGoogle Scholar
  11. Levy, G., andL. P. Amsel (1966) Kinetics of competitive inhibition of salicylic acid conjugation with glycine in man.Bioch. Pharmacol. 15, 1033–1038.CrossRefGoogle Scholar
  12. Lim, R. K. S., D. G. Miller, F. Guzman, D. W. Rodgers, S. K. Wang, P. Y. Chao andT. Y. Shih (1967) Pain and analgesia evaluated by the intraperitoneal bradykininevoked pain method in man.Clin. Pharmacol. Therap. 8, 521–542.CrossRefGoogle Scholar
  13. Lowenthal, W., J. F. Borzelleca andC. D. Corder (1970) Drug absorption from the rectum III: Aspirin and some aspirin derivates,J. Pharm. Sci. 59, 1353–1355.CrossRefPubMedGoogle Scholar
  14. Margolin, S. (1960) Pharmacologic demonstration in man of increased thresholds to tooth pain following carisoprodal and other analgesics.Proc. Soc. Exp. Biol. Med. 105, 531–533.CrossRefPubMedGoogle Scholar
  15. Moolenaar, F., A. G. G. Stuurman-Bieze, J. Visser andT. Huizinga (1978) Biopharmaceutics of rectal administration of drugs in man, part 1: Introduction of benzoic acid as a test drug.Int. Journ. Pharm. 1, 323–336.CrossRefGoogle Scholar
  16. Moolenaar, F., B. Koning and T.Huizinga (1979a), part 7: Absorption rate and bioavailability of phenobarbital and its sodium salt from rectal dosage forms.Int. Journ. Pharm., accepted.Google Scholar
  17. Moolenaar, F., W. J. Greving and T.Huizinga (1979b) part 8: Absorption rate and bioavailability of valproic acid and its sodium salt from different rectal dosage forms.Europ. Journ. Clin. Pharmacol., submitted.Google Scholar
  18. Moolenaar, F., L. Olthof andT. Huizinga (1979c) part 3: Absorption rate and bioavailability of paracetamol from rectal aqueous suspensions,Pharm. Weekblad Sci. Ed. 1, 25–30.Google Scholar
  19. Moolenaar, F., A. J. M. Schoonen, A. Everts andT. Huizinga (1979d) part 4: Absorption rate and bioavailability of paracetamol from fatty suppositories,Pharm. Weekblad Sci. Ed. 1, 89–94.Google Scholar
  20. Neuwald, F., andF. Kunze (1964) Vergleichende Untersuchungen über die Abgabe von Salicylaten aus Suppositorien-fettgrundmassen in vitro und in vivo.Arzneimittel-Forsch. 14, 1162–1167.Google Scholar
  21. Parrot, E. L. (1971) Salicylate absorption from rectal suppositories,J. Pharm. Sci. 60, 867–872.CrossRefGoogle Scholar
  22. Parrot, E. L. (1975) Influence of particle size on rectal absorption of aspirin.J. Pharm. Sci. 64, 878–880.CrossRefGoogle Scholar
  23. Rowland, M., andS. Riegelman (1968) Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man.J. Pharm. Sci. 57, 1313–1319.CrossRefGoogle Scholar
  24. Rowland, M., S. Riegelman, P. A. Harris andS. D. Sholkoff (1972) Absorption kinetics of aspirin in man following oral administration of an aqueous solution.J. Pharm. Sci. 61, 379–385.CrossRefPubMedGoogle Scholar
  25. Rowland, M., S. Riegelman, P. A. Harris, S. D. Sholkoff andE. J. Eyring (1967) Kinetics of acetylsalicylic acid disposition in man.Nature 215, 413–414.CrossRefPubMedGoogle Scholar
  26. Samelius, U., andA. äström (1958) The absorption of an N-methylated barbiturate and acetylsalicylic acid from different suppository masses.Acta Pharmacol. Toxicol. 14, 240–250.CrossRefGoogle Scholar
  27. Schoonen, A. J. M., F. Moolenaar, C. Haverschmidt andT. Huizinga (1976) The interphase transport of drugs from fatty suppository bases.Pharm. Weekblad 111, 585–590.Google Scholar
  28. Schoonen, A. J. M., F. Moolenaar and T.Huizinga (1979) Release of drugs from fatty suppository bases in vitro and in vivo.Int. Journ. Pharm., accepted.Google Scholar
  29. Seed, J. C. (1965) A clinical comparison of the antipyretic potency of aspirin and sodium salicylate.Clin. Pharmacol. Ther. 6, 354–358.CrossRefPubMedGoogle Scholar
  30. Senior, N. (1974)Advances in pharmaceutical sciences. Academic Press, London.Google Scholar
  31. Smith, M. J. H., andP. K. Smith (1966)The salicylates. Interscience, New York.Google Scholar
  32. Superstine, S. Y., E. Superstine andS. Penchas (1978) Comparison of the bioavailability of aspirin tablets and suppositories.Israel. J. Med. Sci. 14, 292–294.PubMedGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1979

Authors and Affiliations

  • F. Moolenaar
    • 1
  • N. J. J. Oldenhof
    • 1
  • W. Groenewoud
    • 1
  • T. Huizinga
    • 1
  1. 1.Laboratorium voor Farmacologie en FarmacotherapieAW GroningenThe Netherlands

Personalised recommendations